Kadowitz PJ - Search Results

1

New approaches to the treatment of pulmonary hypertension: from bench to bedside.

Murthy SN, Nossaman BD, Kadowitz PJ. Murthy SN, et al. Among authors: kadowitz pj. Cardiol Rev. 2010 Mar-Apr;18(2):76-84. doi: 10.1097/CRD.0b013e3181cbcbf3. Cardiol Rev. 2010. PMID: 20160533 Free PMC article. Review.

2

Gene and stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial dysfunction.

Nossaman BD, Gur S, Kadowitz PJ. Nossaman BD, et al. Among authors: kadowitz pj. Curr Gene Ther. 2007 Apr;7(2):131-53. doi: 10.2174/156652307780363161. Curr Gene Ther. 2007. PMID: 17430132 Review.

3

Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats.

Dhaliwal JS, Casey DB, Greco AJ, Badejo AM Jr, Gallen TB, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Dhaliwal JS, et al. Among authors: kadowitz pj. Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1306-13. doi: 10.1152/ajplung.00189.2007. Epub 2007 Aug 31. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17766587 Free article.

4

The role of the RhoA/rho-kinase pathway in pulmonary hypertension.

Nossaman BD, Kadowitz PJ. Nossaman BD, et al. Among authors: kadowitz pj. Curr Drug Discov Technol. 2009 Mar;6(1):59-71. doi: 10.2174/157016309787581057. Curr Drug Discov Technol. 2009. PMID: 19275543 Review.

5

Analysis of pulmonary vasodilator responses to SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a novel aminofurazan-based Rho kinase inhibitor.

Dhaliwal JS, Badejo AM Jr, Casey DB, Murthy SN, Kadowitz PJ. Dhaliwal JS, et al. Among authors: kadowitz pj. J Pharmacol Exp Ther. 2009 Jul;330(1):334-41. doi: 10.1124/jpet.109.151449. Epub 2009 Apr 15. J Pharmacol Exp Ther. 2009. PMID: 19369577 Free PMC article.

6

History of right heart catheterization: 100 years of experimentation and methodology development.

Nossaman BD, Scruggs BA, Nossaman VE, Murthy SN, Kadowitz PJ. Nossaman BD, et al. Among authors: kadowitz pj. Cardiol Rev. 2010 Mar-Apr;18(2):94-101. doi: 10.1097/CRD.0b013e3181ceff67. Cardiol Rev. 2010. PMID: 20160536 Free PMC article.

7

Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.

Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Casey DB, et al. Among authors: kadowitz pj. Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H184-92. doi: 10.1152/ajpheart.00181.2009. Epub 2010 Apr 30. Am J Physiol Heart Circ Physiol. 2010. PMID: 20435851 Free PMC article.

8

Nitrates and nitrites in the treatment of ischemic cardiac disease.

Nossaman VE, Nossaman BD, Kadowitz PJ. Nossaman VE, et al. Among authors: kadowitz pj. Cardiol Rev. 2010 Jul-Aug;18(4):190-7. doi: 10.1097/CRD.0b013e3181c8e14a. Cardiol Rev. 2010. PMID: 20539102 Free PMC article. Review.

9

Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.

Pankey EA, Badejo AM, Casey DB, Lasker GF, Riehl RA, Murthy SN, Nossaman BD, Kadowitz PJ. Pankey EA, et al. Among authors: kadowitz pj. Nitric Oxide. 2012 Jun 30;27(1):1-8. doi: 10.1016/j.niox.2012.02.004. Epub 2012 Mar 14. Nitric Oxide. 2012. PMID: 22426035 Free PMC article.

10

Peroxynitrite has potent pulmonary vasodilator activity in the rat.

Casey DB, Pankey EA, Badejo AM, Bueno FR, Bhartiya M, Murthy SN, Uppu RM, Nossaman BD, Kadowitz PJ. Casey DB, et al. Among authors: kadowitz pj. Can J Physiol Pharmacol. 2012 Apr;90(4):485-500. doi: 10.1139/y2012-012. Epub 2012 Mar 27. Can J Physiol Pharmacol. 2012. PMID: 22452357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

566 results

Search Page